408166
1-(2-吡啶基)哌嗪
≥99%
别名:
2-哌嗪吡啶
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C9H13N3
化学文摘社编号:
分子量:
163.22
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
252-220-3
Beilstein/REAXYS Number:
140423
MDL number:
Assay:
≥99%
Form:
liquid
InChI key
GZRKXKUVVPSREJ-UHFFFAOYSA-N
InChI
1S/C9H13N3/c1-2-4-11-9(3-1)12-7-5-10-6-8-12/h1-4,10H,5-8H2
SMILES string
C1CN(CCN1)c2ccccn2
assay
≥99%
form
liquid
Quality Level
bp
120-122 °C/2 mmHg (lit.)
density
1.072 g/mL at 25 °C (lit.)
正在寻找类似产品? 访问 产品对比指南
General description
1-（2-吡啶基）哌嗪是一种哌嗪衍生物。
Application
1-（2-吡啶基）哌嗪可作为反相 HPLC 测定空气中脂肪族和芳香族异氰酸酯的试剂。 可作为空气中二异氰酸酯荧光测定的试剂。
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
10 - Combustible liquids
wgk
WGK 3
flash_point_f
230.0 °F - closed cup
flash_point_c
110 °C - closed cup
ppe
Eyeshields, Gloves, type ABEK (EN14387) respirator filter
Determination of atmospheric isocyanate concentrations by high-performance thin-layer chromatography using 1-(2-pyridyl) piperazine reagent.
Ellwood PA, et al.
Analyst, 106(1258), 85-93 (1981)
Determination of trace atmospheric isocyanate concentrations by reversed-phase high-performance liquid chromatography using 1-(2-pyridyl) piperazine reagent.
Goldberg PA, et al.
Journal of Chromatography A, 212(1), 93-104 (1981)
Absorption and fluorescence of 1-(2-pyridyl)-piperazine and four diisocyanate derivatives in solution.
Salthammer T, et al.
Journal of Photochemistry and Photobiology A: Chemistry, 107(1), 159-164 (1997)
P Giral et al.
European journal of pharmacology, 134(1), 113-116 (1987-01-28)
We investigated in mice the effects of one of the principal metabolites of buspirone and gepirone, 1-(2-pyridinyl)-piperazine (1-PmP), on hypothermia and reduced locomotion induced by clonidine (0.25 and 0.06 mg/kg, respectively), tests related to brain alpha-adrenergic function. Both effects were
Robert Lavieri et al.
Bioorganic & medicinal chemistry letters, 19(8), 2240-2243 (2009-03-21)
This Letter describes the synthesis and structure-activity relationships (SAR) of isoform-selective PLD inhibitors. By virtue of the installation of a 1,3,8-triazaspiro[4,5]decan-4-one privileged structure, PLD inhibitors with nanomolar potency and an unprecedented 40-fold selectivity for PLD2 over PLD1 were developed. Interestingly
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持